Monday, August 31, 2026
NewsWhite
Samsung Biologics makes $1.8 billion all-cash offer for Switzerland's PolyPeptide Group
WORLD
Unverified

Samsung Biologics makes $1.8 billion all-cash offer for Switzerland's PolyPeptide Group

July 20, 2026Source: CNBC0 views

South Korea's Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland's PolyPeptide Group.

Originally reported by CNBC. Read the original article

Related Articles